B12 deficiency mouth symptoms in 2026: tongue, taste, and burning mouth signs your dentist might catch first

Your tongue goes smooth and red, your mouth burns for no obvious reason, mouth ulcers keep returning. B12 deficiency has oral signatures that appear months before fatigue or neuropathy. Here is what to look for and what to do about it.

Vitamin B12 deficiency is almost always diagnosed late. The reason is timing: the classic markers that flag it on a blood panel, macrocytic anemia and a low serum B12 reading, tend to appear after months or years of declining stores. But the oral cavity tells the story earlier. The cells lining your mouth and tongue turn over rapidly, roughly every 7 to 14 days, and they are among the first tissues to show the effects of impaired DNA synthesis that follows when B12 runs low. Before a patient ever mentions fatigue or pins-and-needles in their hands, their dentist may have seen a red, smooth tongue, recurring ulcers on the inside of the cheeks, or a persistent burning sensation with no apparent local cause.

This is not a niche edge case. The NIH Office of Dietary Supplements estimates that B12 deficiency or insufficiency affects between 3 and 43 percent of adults depending on the population and threshold used, with particularly high rates among older adults, people on plant-based diets, and long-term users of certain medications. Those are large numbers, and most of the affected individuals are not walking around with a diagnosis. They are walking around with a burning tongue, sores that keep coming back, and no idea why.

This guide covers the specific oral signs that should prompt investigation, the mechanism behind each one, which populations carry the highest risk, what absorption barriers exist, how to pick a supplement form, and what the dietary picture looks like. It is grounded in the primary research literature and in the clinical guidance from the Mayo Clinic, the Cleveland Clinic, and peer-reviewed oral medicine publications.

What are the 5 oral signs of B12 deficiency?

Not all of these signs appear in every person, and none of them is pathognomonic (meaning uniquely diagnostic) for B12 deficiency on its own. They gain significance when they cluster, recur, or appear alongside risk factors like a long-term plant-based diet or metformin use. Here is what to watch for, ranked by clinical frequency.

1. Glossitis (smooth, sore, red tongue)
   The most recognized oral sign of B12 deficiency. The normal tongue surface is covered in filiform papillae (thin, thread-like projections) and fungiform papillae (slightly raised, round bumps scattered across the surface). When B12 falls below the level needed to support normal cell turnover, these papillae atrophy and disappear. The result is a smooth, often shiny surface that appears beefy red or, in some cases, pale. The tongue frequently becomes tender, especially during eating or when exposed to heat, spice, or acid. Published case series in the Journal of Oral Rehabilitation document glossitis as the presenting oral sign in a substantial proportion of confirmed B12 deficiency cases, sometimes preceding the blood count findings by months.
2. Burning mouth syndrome (BMS)
   A burning, tingling, or scalding sensation across the tongue, lips, or palate, without visible mucosal damage, is the defining feature of burning mouth syndrome. Secondary BMS, where there is an identifiable cause, includes nutritional deficiencies among the well-documented triggers. B12 (along with iron, zinc, and folate) sits at the top of that list. The mechanism is damage to the small-diameter C and A-delta nerve fibers that supply the oral mucosa. When B12 falls, myelin maintenance fails, these thin fibers misfire, and the brain interprets the aberrant signals as burning or pain. A 2019 systematic review in the Journal of Dentistry identified nutritional deficiency as a correctable cause of BMS that resolved after appropriate supplementation in the majority of reported cases.
3. Recurrent aphthous ulcers (mouth ulcers)
   Most adults experience mouth ulcers occasionally. When they recur more than three or four times a year, particularly large or slow-healing examples, this frequency pattern prompts investigation into nutritional status. Studies in the Journal of Oral Pathology and Medicine have found that a measurable proportion of patients with recurrent aphthous stomatitis have below-normal B12, iron, or folate levels, and that correction of the deficiency reduces frequency and severity of outbreaks. The mechanism involves impaired turnover of the stratified squamous epithelium that lines the cheeks, lips, and floor of the mouth, leaving it more vulnerable to breakdown under mechanical or inflammatory stress.
4. Taste disturbance (hypogeusia or dysgeusia)
   B12 deficiency can blunt taste sensitivity (hypogeusia) or distort it, producing a persistent metallic, bitter, or otherwise abnormal taste (dysgeusia). The taste receptor cells on the tongue turn over every 10 to 14 days and are among the fastest-dividing cells in the body. They are correspondingly vulnerable to any nutritional status that impairs DNA replication, which is precisely what B12 insufficiency does by disrupting the methylation of thymidylate, a step essential to building new DNA strands. Patients often describe the change as food tasting flat, off, or faintly metallic, particularly for sweet and salty stimuli.
5. Pallor of the oral mucosa
   As B12 deficiency progresses to megaloblastic anemia, the reduced red blood cell mass leads to a pale, washed-out appearance of the gums, inner cheeks, and palate. This sign is less early than glossitis but is reliably observed in moderate-to-severe deficiency. Clinicians conducting oral exams routinely compare mucosal color to a personal baseline; pale gums in a previously well-pigmented individual, especially without obvious local cause, should prompt a full blood count and B12 check.

What does a B12 deficiency tongue actually look like?

The term dentists and oral medicine specialists use is glossitis, from the Greek for tongue plus inflammation. In B12 deficiency, the inflammation is secondary to a breakdown in the normal rapid cell renewal of the tongue's epithelial lining. The first thing to go is the filiform papillae, the tiny hair-like projections that give the tongue its normal velvet texture. They atrophy because the cells forming them cannot divide fast enough without adequate B12.

What you see depends on how advanced the deficiency is and how quickly it has progressed. In early or mild deficiency, the change is subtle: the tongue appears slightly smoother than usual, perhaps a little brighter or more uniformly pink. In moderate deficiency, the papillary atrophy becomes pronounced, the surface looks slick and almost polished, and the color shifts to a deeper red, sometimes described as beefy red or magenta, because the vascular bed underneath is now visible without the papillae covering it. In severe or long-standing deficiency, particularly in pernicious anemia, the tongue may be painfully sore, significantly swollen, and show linear fissures or geographic patches.

The critical diagnostic caveat is that glossitis has multiple causes. Geographic tongue, lichen planus, contact allergies, and iron deficiency all produce surface changes that can look superficially similar. The specific diagnostic value of a smooth, red, atrophic tongue is higher when it is accompanied by other oral or systemic signs of B12 deficiency, when it resolves after supplementation, and when it occurs in a person with known risk factors. A dentist or oral medicine specialist who suspects nutritional glossitis will typically refer for a serum B12 test, a full blood count, and in selected cases a serum methylmalonic acid or homocysteine level, both of which are sensitive markers of functional B12 status even when serum B12 is borderline.

Recovery of the tongue surface is possible but gradual. As B12 levels are corrected, papillae regenerate from the basal layer upward. Most patients notice subjective improvement in tongue comfort within 4 to 8 weeks of adequate supplementation. Full visual normalization of the papillary texture can take 3 to 6 months, depending on the depth of the atrophy and the patient's age. Older adults tend to recover more slowly because baseline cell renewal rates are lower.

Can B12 deficiency cause burning mouth syndrome?

Burning mouth syndrome is a real and often debilitating condition: a chronic burning, tingling, or scalding sensation on the tongue, lips, hard palate, or gum tissue, present daily or near-daily, without a visible mucosal lesion to explain it. The Mayo Clinic and Cleveland Clinic both list nutritional deficiency, specifically B12, folate, iron, and zinc, among the known modifiable causes of secondary BMS.

The mechanism connecting B12 to burning mouth is neurological rather than mucosal. B12 is essential for the synthesis of myelin, the lipid-rich insulating sheath that wraps around nerve axons and enables fast, accurate signal transmission. The small-caliber nerve fibers that carry pain and temperature signals from the oral mucosa (unmyelinated C fibers and thinly myelinated A-delta fibers) are particularly vulnerable when myelin cannot be properly maintained, because they rely on B12-dependent methionine synthase activity for the lipid methylation steps involved in myelin production. When these fibers begin to demyelinate or malfunction, they generate spontaneous firing, perceived by the brain as a burning or stinging sensation with no external stimulus.

This is why burning mouth caused by B12 deficiency is classified as a neuropathic pain, not an inflammatory one. There is no redness, no ulcer, no visible pathology to treat locally. The treatment is upstream: correct the deficiency. Published case reports and small cohort studies in oral medicine journals consistently document resolution or substantial improvement in BMS after B12 repletion, with a timeline of 3 to 6 months for neurological recovery. The delay reflects the time needed to rebuild myelin around damaged nerve segments.

One practical point worth noting: burning mouth from B12 deficiency sometimes precedes the tongue changes and the blood abnormalities. This is because thin nerve fibers have a lower threshold for B12-related dysfunction than the rapidly dividing epithelial cells of the tongue surface or the red blood cell precursors in the bone marrow. A patient can have a functionally B12-deficient nervous system, with burning mouth as the only sign, while serum B12 is still within the conventional normal range, because serum B12 does not always reflect tissue-level availability. Methylmalonic acid, a metabolite that accumulates when B12-dependent reactions are stalled, provides a more functionally sensitive marker in this situation.

Why does B12 deficiency show up in the mouth first?

The oral mucosa is one of the most metabolically active tissues in the body. The cells lining your mouth, gums, and tongue replace themselves every 7 to 14 days. That turnover rate is comparable to the gut lining and far faster than skin or bone. This rapid renewal requires massive amounts of DNA synthesis, and DNA synthesis requires adequate B12.

The specific biochemical step that B12 enables is the conversion of homocysteine to methionine, catalyzed by the enzyme methionine synthase. Methionine is then converted to S-adenosylmethionine (SAM), the universal methyl donor used in hundreds of cellular reactions including the methylation of uracil to thymidine, a step required to build new strands of DNA. When B12 falls, this pathway stalls. Cells that need to divide rapidly, the mucosal cells of the mouth and tongue, the papillae-forming cells, the taste receptor cells, find themselves unable to complete normal cell division. The consequence is a condition called megaloblastic change: cells grow large and abnormal because they cannot divide cleanly. The tissue becomes structurally compromised, papillae atrophy, ulcers form more easily, and the integrity of the mucosal barrier weakens.

The same biochemical blockade causes megaloblastic anemia, where red blood cell precursors in the bone marrow grow large and malformed. But bone marrow cells have a longer lifespan buffer before the clinical anemia becomes obvious on a blood count. Oral mucosal cells, turning over every two weeks, show the damage faster. This is why the mouth is an early-warning tissue for B12 deficiency, the same way it is for folate, iron, and zinc deficiency, all of which produce oral signs through variants of the same mechanism.

The neurological component adds a second, independent channel. B12 is required for the methylation reactions that maintain the myelin sheath on peripheral nerves. The thin nerve fibers supplying the tongue and oral mucosa are among the earliest to show dysfunction because they have relatively little myelin to begin with, making them less tolerant of any reduction in myelin production. This is why burning, tingling, or numbness in the mouth can precede similar sensations in the hands and feet, the classic early neuropathy sites, in some B12-deficient individuals.

Which 3 groups are at highest risk of B12 deficiency?

B12 deficiency has two routes to developing: inadequate dietary intake and inadequate absorption. Different risk groups are primarily exposed through one or the other, but the clinical outcome, depleted B12 stores and eventual tissue-level deficiency, is the same. Here are the three groups that carry the highest documented risk.

1. Vegans and strict vegetarians
   Vitamin B12 is produced by bacteria and archaea and accumulates in animal tissues. It is not present in unfortified plant foods in meaningful amounts. Algae like spirulina contain B12-like compounds (pseudocobalamins) that may actually block active B12 absorption and should not be relied upon as a source. The NIH Office of Dietary Supplements notes that vegans who do not supplement consistently or eat fortified foods will deplete their B12 stores over years and eventually develop deficiency. The timeline is longer than many assume because the liver stores 2 to 5 mg of B12, enough for 3 to 5 years of zero intake. But as those stores fall, the oral signs often appear before the blood count changes become unmistakable. Oral glossitis and recurrent aphthous ulcers in a vegan with no supplementation habit is a pattern that should prompt immediate blood testing.
2. Adults over 60
   Roughly 6 percent of adults over 60 and up to 20 percent of adults over 80 have B12 deficiency by conventional serum cutoffs, with a further significant proportion in the subclinical insufficiency range. The primary mechanism is atrophic gastritis, a progressive thinning of the stomach lining that reduces both gastric acid production and intrinsic factor secretion. Reduced gastric acid matters because dietary B12 in food is bound to food proteins, and hydrochloric acid is needed to cleave it free before intrinsic factor can bind it. When acid production falls, even a B12-rich diet becomes functionally inadequate. Crystalline B12 in supplements does not require this acid-cleavage step and is absorbed directly, which is why high-dose oral or sublingual supplementation can bypass this particular bottleneck.
3. People taking metformin or proton pump inhibitors long-term
   Metformin, the first-line type 2 diabetes medication used by tens of millions of adults worldwide, reduces B12 absorption through a mechanism that is not fully characterized but appears to involve impaired calcium-dependent ileal receptor function for the intrinsic factor-B12 complex. Clinical evidence, including a 2019 analysis in the Journal of Gastroenterology, shows that metformin use of more than 4 years is associated with a statistically significant decrease in serum B12. Proton pump inhibitors (PPIs) such as omeprazole, esomeprazole, and pantoprazole reduce gastric acid secretion by up to 90 percent. Since gastric acid is necessary to release food-bound B12, long-term PPI use impairs B12 absorption from dietary sources. Both medications are prescribed chronically to tens of millions of patients in high-income countries, and monitoring B12 annually in long-term users is recommended by the American Diabetes Association for metformin users.

Two additional populations bear mentioning: people with autoimmune conditions that affect the stomach (pernicious anemia, autoimmune gastritis) face the most complete absorption failure of any group, and individuals who have had gastric surgery including bariatric procedures lose varying amounts of intrinsic-factor-producing capacity depending on the type and extent of the surgery. Both populations typically require parenteral (injected) or very high-dose oral B12 rather than standard supplement doses.

Why is B12 so hard to absorb?

B12 has the most complex absorption pathway of any known vitamin. The process involves multiple proteins, two separate sections of the gastrointestinal tract, and a receptor-mediated active transport step that fails the moment intrinsic factor is absent. Understanding why absorption fails explains why so many people become deficient despite eating B12-containing foods.

The pathway begins in the mouth. Salivary glands secrete a binding protein called haptocorrin (formerly known as R protein or transcobalamin I), which grabs B12 in the mouth and carries it through the stomach. In the acidic stomach, gastric acid frees food-bound B12 from its protein matrix. Parietal cells in the stomach wall produce intrinsic factor, which waits in the stomach while haptocorrin keeps the B12 safe from acid. In the duodenum (the first section of the small intestine), pancreatic enzymes digest haptocorrin, releasing the B12. Intrinsic factor then binds the free B12, forming the intrinsic factor-B12 complex. This complex travels to the terminal ileum, the final section of the small intestine, where specialized receptors (cubam, consisting of cubilin and amnionless proteins) bind the complex and enable active transport across the intestinal wall into the bloodstream.

Any disruption at any step of this cascade impairs absorption. Reduced gastric acid (from aging or PPIs) means food-bound B12 is not released. Reduced intrinsic factor (from atrophic gastritis or pernicious anemia) means the B12 cannot reach the terminal ileum receptor. Reduced pancreatic enzyme output means haptocorrin is not digested and intrinsic factor cannot bind. Terminal ileal disease or resection (from Crohn's disease, ileostomy, or bariatric surgery) destroys the absorption site entirely. This is why injection bypasses all of these barriers: hydroxocobalamin injected intramuscularly enters the bloodstream directly without needing any of the gastrointestinal machinery.

There is one additional route for B12 absorption that does not require intrinsic factor: passive diffusion across the intestinal mucosa. This occurs at roughly 1 percent efficiency from any dose. At very high oral doses (1,000 to 2,000 micrograms), the 1 percent passive absorption becomes sufficient to maintain B12 status even with complete intrinsic factor failure. This is the rationale for high-dose oral B12 therapy in patients who refuse injections or find them impractical.

Methylcobalamin vs cyanocobalamin vs hydroxocobalamin: which form should you take?

There are four forms of B12 supplement in clinical use: methylcobalamin, cyanocobalamin, hydroxocobalamin, and adenosylcobalamin. Supplement marketing has made this more confusing than it needs to be, often by implying one form is categorically superior. The actual picture depends on your specific situation.

For most people with dietary B12 deficiency, cyanocobalamin remains a sound choice: it is inexpensive, stable, and supported by the largest evidence base. The concern about cyanocobalamin releasing a tiny amount of cyanide upon conversion is not clinically relevant at standard supplement doses; the cyanide load is trivially small compared to what you absorb from a diet containing any cruciferous vegetables, and people with normal kidney function excrete it without issue. The only population where cyanocobalamin is specifically discouraged is people with Leber's hereditary optic neuropathy, a rare mitochondrial condition.

Methylcobalamin is the form to consider when the primary concern is neurological: burning mouth, peripheral neuropathy, or cognitive symptoms. It enters the nervous system directly without requiring metabolic conversion, making it available faster to the nerve repair processes that need it. Several Japanese trials on B12 neuropathy specifically used methylcobalamin rather than cyanocobalamin, and Japanese neurological practice has favored it for decades. For oral symptoms specifically, where the concern is the thin-fiber neuropathy causing burning mouth, methylcobalamin is the form most clinicians familiar with the literature would reach for first.

Hydroxocobalamin injections are the clinical standard for pernicious anemia and other severe absorption-failure cases in most European countries. The body converts it to both methylcobalamin and adenosylcobalamin as needed, and its retention time in the body is longer than cyanocobalamin injections, which is why dosing frequency is lower. In the UK's National Health Service, hydroxocobalamin injections are given every 3 months for maintenance after pernicious anemia is confirmed.

Which foods actually contain meaningful amounts of B12?

The dietary picture for B12 is straightforward in principle and complicated in practice. B12 is synthesized exclusively by certain bacteria and archaea. It accumulates through the food chain: bacteria in the gut and environment produce it, animals eat bacteria or accumulate it from food, and humans get it primarily from animal products. Here is what the food sources actually look like by typical serving contribution.

The richest sources by far are beef liver and other organ meats (up to 70 to 80 mcg per 3-ounce serving), shellfish particularly clams (up to 84 mcg per 3-ounce serving), and smaller but still significant amounts in beef, salmon, tuna, trout, and dairy products. The adult recommended dietary allowance (RDA) for B12 in most regulatory systems sits at 2.4 micrograms per day; older adults and pregnant or breastfeeding women have slightly higher needs. A single 3-ounce serving of beef provides roughly 2 to 3 mcg; a cup of milk provides about 1 mcg; an egg provides 0.6 mcg. Regular consumption of a mixed omnivorous diet covering these sources should maintain adequate status in people with normal absorption.

Plant-based B12 sources are limited to fortified foods: plant milks, breakfast cereals, nutritional yeast, and some meat analogues are fortified with crystalline cyanocobalamin. The fortification levels vary significantly by product and brand. Fortified plant milk typically provides 1 to 3 mcg per cup, which is enough if consumed consistently but leaves no buffer for days of lighter intake. The NIH Office of Dietary Supplements consistently notes that vegans require either reliable supplementation or consistent use of multiple B12-fortified foods daily to meet needs, and that dietary survey data consistently shows most vegans not achieving adequate B12 intake from food alone.

The absorption efficiency from food adds another layer. The body absorbs approximately 50 percent of the B12 from animal foods at normal meal-sized doses through the intrinsic factor pathway. As a meal's B12 content increases beyond about 1 to 2 mcg, absorption percentage falls due to intrinsic factor saturation; you cannot absorb unlimited B12 from a single meal. This is relevant for people who attempt to address deficiency purely through dietary changes rather than supplements: even doubling intake from food may not produce the rapid repletion that supplementation achieves.

How do you actually test for B12 deficiency?

The standard first test is serum B12, a routine blood draw. The conventional normal range in most laboratories runs from approximately 200 to 900 pg/mL, with values below 200 pg/mL classified as deficient and values from 200 to 300 pg/mL classified as borderline or low-normal. The problem is that serum B12 measures the total B12 circulating in the blood, including forms bound to haptocorrin that are not actually available to tissues. A patient can have a normal serum B12 while their cells are starved of the functional, biologically available form.

The more functionally sensitive markers are serum methylmalonic acid (MMA) and plasma homocysteine. Methylmalonic acid is a compound that accumulates in the blood when the B12-dependent enzyme methylmalonyl-CoA mutase cannot process it. Elevated MMA is a specific signal that B12-dependent metabolism is impaired at the cellular level, even when serum B12 appears normal. Homocysteine rises when the methionine synthase reaction is stalled, which can indicate B12 deficiency but also folate or B6 deficiency. MMA is generally considered the more specific marker for B12, while homocysteine provides broader nutritional context.

A full blood count (FBC or CBC) provides another angle. B12 deficiency that has progressed to megaloblastic anemia shows up as elevated mean corpuscular volume (MCV), meaning the red blood cells are larger than normal. An MCV above 100 fL in an adult with no other explanation (alcohol excess, hypothyroidism, liver disease, certain medications) should prompt B12 and folate testing. The combination of elevated MCV plus low serum B12 is a highly suggestive pattern.

If deficiency is confirmed, the next clinical question is whether intrinsic factor is working. Anti-intrinsic factor antibodies (the serological marker for pernicious anemia) are present in roughly 50 to 70 percent of pernicious anemia cases. A negative anti-IF antibody test does not rule out pernicious anemia because the antibody is not always detectable, but a positive result in a B12-deficient patient points toward autoimmune gastric pathology and changes the treatment approach significantly, since oral supplements will not correct the deficiency reliably and injections become standard of care.

What actually resolves B12-related oral symptoms?

The answer is straightforward in principle: correct the deficiency and the oral symptoms resolve. But the timeline matters, and local oral care during recovery is not irrelevant.

Glossitis (the smooth red tongue) typically starts improving within 4 to 8 weeks of starting adequate B12 supplementation. The subjective soreness and tenderness often ease before the visual texture returns to normal. Full papillary regrowth takes 3 to 6 months in most cases, and longer in older adults or those with longstanding deficiency. Research published in the Journal of Oral Rehabilitation documents this recovery trajectory in patients treated for confirmed B12 deficiency, with parallel improvement in tongue symptoms and systemic markers over the same 3 to 6 month window.

Recurrent aphthous ulcers associated with B12 deficiency typically reduce in frequency within 4 to 12 weeks of supplementation. A small controlled trial published in the Journal of Clinical Dentistry found that sublingual B12 reduced the frequency of aphthous recurrences in deficient patients regardless of the initial serum B12 level, suggesting functional B12 supplementation is beneficial even in patients with borderline rather than frank deficiency. Patients who have lived with frequent recurrent ulcers for years and considered it their baseline sometimes find that supplementation resolves what they had accepted as a chronic normal condition.

Burning mouth caused by B12-related thin-fiber neuropathy takes the longest to resolve: 3 to 6 months of consistent supplementation is the typical timeline quoted in oral medicine literature, and some patients with longstanding nerve damage take 9 to 12 months or longer. The myelin repair process is slow and cannot be safely accelerated. Patients should be counseled to continue supplementation through the entire recovery window rather than stopping when blood levels normalize, since tissue-level repair continues after the serum marker has corrected.

Taste disturbance typically resolves within 6 to 12 weeks as the taste receptor cells regenerate with adequate B12 supply. Many patients report this as one of the more striking improvements: foods they had written off as bland or odd-tasting return to normal intensity. This recovery can be a useful subjective indicator that supplementation is working before all the mucosal signs fully normalize.

During the recovery period, local oral care still matters. The compromised mucosal integrity during active deficiency means the oral tissue is more vulnerable to further irritation from acidic foods, alcohol-based mouthwashes, and SLS-containing toothpastes (sodium lauryl sulfate, which some research suggests increases aphthous ulcer frequency by disrupting the mucosal protective film). Soft-bristle brushing, avoiding abrasive oral hygiene products, and using alcohol-free, SLS-free rinses reduces local irritation while the underlying nutritional deficiency is being corrected. Supporting the oral environment from the outside while the body repairs from the inside is not a cure, but it reduces symptom burden during the months the process takes.

Frequently asked questions